Kunming Longjin Pharmaceutical News

Kunming Longjin Pharmaceutical: Stock trading has experienced abnormal fluctuations announcement.

Jul 18 12:00 ET

Kunming Longjin Pharmaceutical: Stock trading has experienced abnormal fluctuations announcement.

Jul 15 12:00 ET

Kunming Longjin Pharmaceutical: 2024 Interim Performance Forecast

Jul 10 12:00 ET

Kunming Longjin Pharmaceutical: Announcement on the Implementation of Shareholding Reduction by Shareholders.

Jul 5 12:00 ET

Kunming Longjin Pharmaceutical: Stock trading has experienced abnormal fluctuations announcement.

Jul 3 12:00 ET

Kunming Longjin Pharmaceutical: Stock trading has experienced abnormal fluctuations announcement.

Jun 3 12:00 ET

Kunming Longjin Pharmaceutical: Notice of abnormal fluctuations in stock trading

May 29 12:00 ET

Kunming Longjin Pharmaceutical: Response from China Audit Zhonghuan Certified Public Accountants (Special General Partnership) to the inquiry letter on the 2023 annual report of Kunming Longjin Pharmaceutical Co., Ltd.

May 27 12:00 ET

Kunming Longjin Pharmaceutical: Notice of Response to the 2023 Annual Report Inquiry Letter

May 27 12:00 ET

Kunming Longjin Pharmaceutical: Notice of abnormal fluctuations in stock trading

May 23 12:00 ET

Kunming Longjin Pharmaceutical: 2023 Annual General Meeting of Shareholders Legal Opinions

May 21 12:00 ET

Kunming Longjin Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders

May 21 12:00 ET

Kunming Longjin Pharmaceutical: Notice of Serious Unusual Fluctuations in Stock Trading

May 20 12:00 ET

Kunming Longjin Pharmaceutical: Notice of abnormal fluctuations in stock trading

May 15 12:00 ET

Kunming Longjin Pharmaceutical: 002750*ST Longjin Investor Relations Management Information 20240514

May 14 01:30 ET

Kunming Longjin Pharmaceutical: Notice of abnormal fluctuations in stock trading

May 12 12:00 ET

Kunming Longjin Pharmaceutical: Announcement on participating in the 2023 Investor Online Group Reception Day for Listed Companies in Yunnan

May 8 12:00 ET

Kunming Longjin Pharmaceutical: Notice of abnormal fluctuations in stock trading

May 7 12:00 ET

Kunming Longjin Pharmaceutical: Summary report of the Board Audit Committee on the evaluation of the accounting firm's performance in 2023

May 5 12:00 ET

Kunming Longjin Pharmaceutical: 2024-A004 Special Verification Report on the 2023 Operating Income Deduction Status Table

Apr 29 12:00 ET